BIOSIMILARS - Regulatory Framework and Pipeline Analysis

ReportsWeb.com has announced the addition of the “Global BIOSIMILARS Market Research Report 2017” The report focuses on global major leading industry players with information such as company profiles, product picture and specification.

Biosimilars are copied versions of biologics that offer a 20-50% reduction in cost compared with innovative biologic products. Biosimilars are getting the world wide attention as the cost of the innovative biologics are enormously high and even minimal reduction in price will reduce the healthcare spending substantially. All the countries are focusing on reducing the healthcare expenditure and biosimilars compliments to this goal. Biologic products are complex in structure and follow a complex manufacturing process thus, some variation exists between the reference product and its biosimilar. It is very important to assess the variations in biosimilars by comparing with reference product to ensure quality, non-clinical, and clinical properties, which has given rise to the regulatory requirements for biosimilars. Regulatory requirement for approving biosimilars varies across different regulatory bodies. However, all the countries have derived the basic theme from EMA and WHO guidelines for framing their regulatory structure. There is a need to harmonize the nomenclature of biosimilars, extrapolation of indications, and interchangeability of biosimilars with reference products across the regulatory bodies. Biosimilars market is developing and it could be well established with the pipeline that is poised to deliver a wave of biosimilars in the market in the near future

Request a Sample copy at http://www.reportsweb.com/biosimilars-regulatory-framework-and-pipeline-analysis

Scope of the Report

The scope of the report includes -
- Introduction
- Market dynamics: Trends, Drivers, and Barriers
- WHO guidance for biosimilars
- Regulatory overview, biosimilar guidelines, regulatory framework for biosimilars, and market outlook for: Europe, USA, India, South Korea, Japan and China.
- Key players
- Pipeline Analysis
- Overview
- By Stage of Development / Molecule / Therapy Area / Indication
- Late-Stage / Phase II / Phase I Pipeline Biosimilars

Complete report is available at http://www.reportsweb.com/inquiry&RW0001170002/sample

The report will enhance your decision-making capability by allowing you to -
- Understand the regulatory requirement and regulatory framework that facilitates effective product development strategy as biosimilars industry is currently highly focused, growing, and outpacing the growth rate of small molecule pharmaceutical market
- Targeting geographies would be easy by comparing different regulatory frameworks; this would also provide a base for designing a strategy to enter the developed markets. Biosimilars are of interest in developed countries to reduce the healthcare expenditure
- With the recent approvals of biosimilars by USFDA, the biosimilars market is going to grow and this report examines the post approval market landscape
- Examine the biosimilars pipeline and specifies the products that are highly targeted, it also includes analysis of highly focused indications, mechanism of actions, and therapy areas in the pipeline
- Analyze the details of the clinical pipeline that includes late stage products, Phase II, and Phase I products. Detailed understanding of the pipeline will help in targeting the products for development, rate the current products and predict the competition

Executive Summary
Introduction
Biosimilars Industry Dynamics
Trends
Drivers
Restraints
Biosimilars Regulation: WHO's Guidance
Biosimilars in Europe
Overview
Regulatory Framework
Market Outlook
Biosimilars in the US
Overview
Regulatory Framework
Market Outlook
Biosimilars in India
Overview
Regulatory Framework
Market Outlook
Biosimilars in South Korea
Overview
Regulatory Framework
Market Outlook
Biosimilars in Japan
Overview
Regulatory Framework
Market Outlook
Biosimilars in China
Overview
Regulatory Framework
Market Outlook
Key Market Players
Biosimilars Pipeline Analysis
Overview
By Stage of Development
By Molecule
By Therapy Area
By Indication
By MoA/RoA
Late-Stage Pipeline Biosimilars
Phase II Pipeline Biosimilars
Phase I Pipeline Biosimilars

Contact Us:                          
Call: +1-646-491-9876
Email: sales@reportsweb.com

ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.

Pune:
505, 6th floor, Amanora Township,
Amanora Chambers, East Block,
Kharadi Road, Hadapsar, Pune-411028

This release was published on openPR.